Astellas Access ProgramSM for Adenoscan
Astellas is committed to supporting and maintaining access to medications for patients who are treated with an Astellas product.
The Astellas Access ProgramSM (AAP) was established to provide no-cost stock replacement of injectable/infused medications that have been administered to qualifying uninsured patients. Patients must meet specific criteria to qualify for assistance.
For your convenience, you can initiate a Stock Replacement Request online at Astellas eService. For any additional questions about the Astellas Access ProgramSM, you can call
- Download AAP Overview Flashcard (PDF - 298 KB)
